APC and intestinal neoplasm: Engineered E. coli Nissle 1917 (EcN) expressing selected CMCPs administered to Apc<sup>min/+</sup> mice selectively colonize intestinal tumors, deliver functional CMCPs in situ, and elicit significant antitumor immune responses while reducing tumor burden.